Drugmaker Eli Lilly Announces 70% Price Drop In Its 'Most Commonly Prescribed Insulins'
Big news this morning for anyone who relies on insulin: Drug manufacturer Eli Lilly announced that it's cutting the price by 70% on its "most commonly prescribed insulins."
Some details: The company's also expanding its Insulin Value Program, which caps patient out-of-pocket costs at $35 or less per month.
Why now: The announcement comes after waves of criticism saying the drug, vital to many people with diabetes, should be more accessible. The price of insulin has increased 600% over the last 20 years and prompted California lawmakers to commit to producing the state's own brand of generic insulin to sell at below-market prices.
Why it matters: According to the American Diabetes Association, 8 million people in the U.S. with diabetes rely on insulin — about 4 million of those in California. Eli Lilly dominates the insulin market, along with two other competitors. Patients often struggle to pay the high costs of the life-saving drug, even when they're insured.
April Valentine died at Centinela Hospital. Her daughter was born by emergency C-section. She'd gone into the pregnancy with a plan, knowing Black mothers like herself were at higher risk.
Before navigating domestic life in the United States, AAPI immigrants often navigated difficult lives in their motherlands, dealing with everything from poverty to war.
There are plenty of factors in life that contribute to happiness. But could keeping in touch with your loved ones be the most important?
The new California law makes it a crime to sell flavored tobacco products, including menthol cigarettes.
CVS And Walgreens Agree To Pay $10B — About $510M To California — To Settle Lawsuits Linked To Opioid SalesCalifornia is expected to get about $510 million from the settlement
#Snapback perpetuates unrealistic postpartum expectations.